UK markets closed

4D pharma plc (DDDD.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
136.00-10.00 (-6.85%)
At close: 4:35PM GMT
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
Total revenue
211
211
0
0
Operating expenses
Research development
26,512
26,512
24,908
16,911
Selling general and administrative
1,572
1,572
2,239
2,128
Total operating expenses
30,825
30,825
29,119
20,361
Operating income or loss
-30,614
-30,614
-29,119
-20,361
Interest expense
514
514
348
123
Income before tax
-29,426
-29,426
-28,437
-23,986
Income tax expense
-5,360
-5,360
-4,747
-3,541
Income from continuing operations
-24,066
-24,066
-23,690
-20,445
Net income
-24,066
-24,066
-23,690
-20,445
Net income available to common shareholders
-24,066
-24,066
-23,690
-20,445
Basic EPS
-
-0.37
-0.36
-0.31
Diluted EPS
-
-0.37
-0.36
-0.31
Basic average shares
-
65,494
65,494
65,085
Diluted average shares
-
65,494
65,494
65,085
EBITDA
-
-27,631
-26,888
-22,881